DongHua Testing Technology (300354.SZ) released its forecast, expecting a net profit of 120 million to 150 million yuan in 2024, a year-on-year increase of 36.75% to 70.94%.
Donghua Testing (300354.SZ) announced that the company expects its net profit attributable to shareholders of the listed company in 2024...
DongHua Testing Technology (300354.SZ) announced that the company expects a net profit attributable to shareholders of the listed company of 120 million to 150 million yuan in 2024, a year-on-year increase of 36.75% to 70.94%.
Related Articles
Coherent (COHR.US) 2026 fiscal year second quarter conference call: CPO recently received a large order.
Zhejiang Ausun Pharmaceutical (603229.SH) cooperated product Tofacitinib Citrate Tablets obtained overseas marketing approval.
Zhongjin: Increased Overseas Coal Supply Disruption Increases Risk and Warms up Coal Price Upside.
Coherent (COHR.US) 2026 fiscal year second quarter conference call: CPO recently received a large order.
Zhejiang Ausun Pharmaceutical (603229.SH) cooperated product Tofacitinib Citrate Tablets obtained overseas marketing approval.
Zhongjin: Increased Overseas Coal Supply Disruption Increases Risk and Warms up Coal Price Upside.
